Cartesian Therapeutics

Principal Scientist Nonclinical Development and Translational Sciences About Cartesian Therapeutics:Cartesian Therapeutics is a late clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Companys lead asset Descartes-08 is a CAR-T in Phase 3 clin

Principal Scientist Nonclinical Development and Translational Sciences About Cartesian Therapeutics:Cartesian Therapeutics is a late clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Companys lead asset Descartes-08 is a CAR-T in Phase 3 clin

Research Operations and Nonclinical Development Manager About Cartesian Therapeutics:Cartesian Therapeutics is a late clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Companys lead asset Descartes-08 is a CAR-T in Phase 3 clinical developmen

Research Operations and Nonclinical Development Manager About Cartesian Therapeutics:Cartesian Therapeutics is a late clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Companys lead asset Descartes-08 is a CAR-T in Phase 3 clinical developmen